Lyme Quant C6® Test

(Lyme Quantitative C6 Antibody Test)

Answers to your toughest Lyme disease questions

 

As part of a two-tiered approach, this breakthrough laboratory test helps you diagnose, quantify, manage and monitor Lyme-infected dogs.

Now you can quickly identify Lyme infection in canine patients and use valuable, measurable information to monitor your treatment choice.

 
Lyme Quant C6® Test

Know it all about Lyme disease? Find out by taking our quiz >

C6 technology lets you monitor response to treatment

A unique property of the C6 antibody is that levels decline sharply after treatment, before the body can produce memory (B) cells. The lack of memory (B) cells means the body does not maintain a titer after the spirochetes are killed.

Other tests, such as the Lyme titer (IFA) and Western blot tests, measure antibodies that can persist at high levels long after treatment, making it difficult to determine whether the spirochetes are still present, even after treatment.

IDEXX Lyme Quant C6: chart

Case Study

IDEXX Lyme Quant C6: Wilbur case study

Lyme Quant C6® Tests available

Test CodeName and Contents

7246

Lyme Quant C6® Antibody by ELISA

72461

Add-on Lyme Quant C6® Antibody by ELISA

2360

Lyme Quant C6® Monitoring Profile

Chem 11, comprehensive CBC, Lyme Quant C6®, urinalysis, urine protein:creatinine ratio

2826

Tick Panel (RealPCR™ Panel) with Lyme Quant C6®

Anaplasma spp., Ehrlichia spp. and Rocky Mountain spotted fever RealPCR™ tests, Lyme Quant C6®

3716

Tick Panel with Lyme Quant C6®*

Ehrlichia canis and Rocky Mountain spotted fever by IFA, Lyme Quant C6®

37161

Add-on Tick Panel with Lyme Quant C6®*

2822

Tick Panel 4 (RealPCR™ Panel) with Lyme Quant C6®

Anaplasma spp. and Ehrlichia spp. RealPCR™ tests, Lyme Quant C6®

2354

Tick Panel 4 with Lyme Quant C6®

Anaplasma phagocytophilum and Ehrlichia canis antibodies by IFA, Lyme Quant C6®*

2355

Add-on Tick Panel 4 with Lyme Quant C6®

2356

Tick Panel 6 with Lyme Quant C6®*

Anaplasma phagocytophilum, Ehrlichia canis and Rocky Mountain spotted fever antibodies by IFA, Lyme Quant C6®*

2357

Add-on Tick Panel 6 with Lyme Quant C6®*

2295

Tick Panel 14 with Lyme Quant C6®*

Anaplasma phagocytophilum and Rocky Mountain spotted fever antibodies by IFA, Lyme Quant C6®

13896

Tick Profile with Lyme Quant C6®

Chem 25, comprehensive CBC, Ehrlichia canis and Rocky Mountain spotted fever antibodies by IFA, Lyme Quant C6®

2828

Tick/Vector Canine Comprehensive RealPCR™ Panel and Lyme Quant C6®

Anaplasma spp., Babesia spp., Bartonella spp., Canine Hemotropic Mycoplasma, Ehrlichia spp., Hepatozoon spp., Leishmania spp., Neorickettsia spp. and Rocky Mountain spotted fever RealPCR™ tests, Lyme Quant C6®

2327

Total Health™ with Lyme Quant C6®

Chem 27, comprehensive CBC, Lyme Quant C6®

 

*
More diagnostic information is available with these add-ons: Urinalysis (code 9101) and FeLV Antigen and FIV Antibody by ELISA (code 1045).

Specimen Requirements:

Lab 4Dx® Screen: 1 mL serum

Fecal Ova and Parasites by Zinc Sulfate Centrifugation: 3–5 g fresh feces in a sterile container per specimen

Lyme Quant C6 Antibody by ELISA: 1 mL serum

Chem 10 (Albumin, albumin:globulin ratio, alkaline phosphatase, ALT (SGPT), BUN, BUN:creatinine ratio, creatinine, globulin, glucose, total protein): 1 mL serum

CBC: 1 mL LTT, two blood smears

T4:  1 mL serum

A two-tiered approach to Lyme disease management

Tier 1
Screen with the SNAP® 3Dx® or 4Dx® Test to identify Lyme infection in clinical and subclinical dogs.
Studies show that the SNAP 3Dx/4Dx Lyme C6 peptide has shown little or no cross-reactivity with current Lyme vaccines.1
You’ll know for sure if a dog is infected.
Tier 2
Follow up Lyme-positives with a Lyme Quant C6 Test.
This reference laboratory test helps you quantify infection level so you’ll know when treatment is warranted.
You can monitor these patients with a six-month convalescent test to assess response to treatment and have a new baseline in case re-infection occurs.
Reference
1.
Liang FT, Jacobson RH, Straubinger RK, Grooters A, Philipp MT. Characterization of a Borrelia burgdorferi VisE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol. 2000;38(11):4160–66.